Do dual GIP/GLP-1 receptor agonists reduce the incidence of hard clinical outcomes, such as myocardial infarction and stroke, compared with GLP-1 receptor agonists?

Current evidence suggests that dual GIP/GLP-1 receptor agonists, like tirzepatide, may offer benefits comparable to GLP-1 receptor agonists concerning cardiovascular outcomes, but no superior efficacy for reducing myocardial infarction or stroke incidents has been demonstrated directly.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23753935
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Do dual GIP/GLP-1 receptor agonists reduce the incidence of hard clinical outcomes, such as myocardial infarction and stroke, compared with GLP-1 receptor agonists?

Tripdatabase
2 links
Zenodo (CERN European Organization for Nuclear Research)
Diabetes Treatment and Management
article

Do dual GIP/GLP-1 receptor agonists reduce the incidence of hard clinical outcomes, such as myocardial infarction and stroke, compared with GLP-1 receptor agonists?

Tripdatabase
article en

Abstract

Current evidence suggests that dual GIP/GLP-1 receptor agonists, like tirzepatide, may offer benefits comparable to GLP-1 receptor agonists concerning cardiovascular outcomes, but no superior efficacy for reducing myocardial infarction or stroke incidents has been demonstrated directly.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 11%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Do dual GIP/GLP-1 receptor agonists reduce the incidence of hard clinical outcomes, such as myocardial infarction and stroke, compared with GLP-1 receptor agonists? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS